Nevertheless, we believed that our research could facilitate understanding of clinical value of circadian rhythm in cervical cancer, and unleash probability of digging into the prognostic value and even targetable features of circadian clock gene sets in cancer biology. The gene discussed is CLOCK; the disease is cervical carcinoma.